John Menzies plc buy krebskrebs
Start price
05.10.20
/
50%
€1.23
Target price
04.11.21
€2.00
Performance (%)
196.75%
End price
05.11.21
€3.65
Summary
This prediction ended on 05.11.21 with a price of €3.65. The BUY prediction by krebskrebs for John Menzies plc saw massive gains of 196.75%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
John Menzies plc | - | - | - | - |
iShares Core DAX® | -1.114% | 5.062% | 24.922% | 25.215% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% | 44.324% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% | 12.395% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% | 43.899% |
Comments by krebskrebs for this prediction
In the thread John Menzies plc diskutieren
Buy mit Kursziel 2,0
In the thread Trading John Menzies plc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten